Literature DB >> 15024894

Male hypogonadism in the primary care clinic.

Nicole N Grant1, Bradley D Anawalt.   

Abstract

Hypogonadism is common in clinical practice but is frequently unrecognized and underdiagnosed. The common causes of male hypogonadism vary with the age of presentation. The overall prevalence of male hypogonadism based upon low serum total testosterone levels is high and increases with age. There are many pitfalls in making the diagnosis of male hypogonadism. First, male hypogonadism is sometimes difficult to recognize because the signs and symptoms are often nonspecific and overlap with other common syndromes. Second, the biochemical diagnosis of male hypogonadism is not straightforward because it might not be clear which testosterone assay to select from the many that are available. Finally, even after the diagnosis of male hypogonadism is made, the patient and clinician must weigh the potential benefits and risks of androgen replacement therapy. However, new diagnostic tools and therapies are making decisions easier.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15024894     DOI: 10.1016/s0095-4543(03)00091-5

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  3 in total

1.  Pain interference and incident mood, anxiety, and substance-use disorders: findings from a representative sample of men and women in the general population.

Authors:  Declan T Barry; Corey E Pilver; Rani A Hoff; Marc N Potenza
Journal:  J Psychiatr Res       Date:  2013-08-27       Impact factor: 4.791

2.  Prevalence and psychiatric correlates of pain interference among men and women in the general population.

Authors:  Declan T Barry; Corey Pilver; Marc N Potenza; Rani A Desai
Journal:  J Psychiatr Res       Date:  2011-09-23       Impact factor: 4.791

3.  The Association Between Alcohol Consumption and Pain Interference in a Nationally Representative Sample: The Moderating Roles of Gender and Alcohol Use Disorder Symptomatology.

Authors:  Ellen W Yeung; Matthew R Lee; Yoanna McDowell; Kenneth J Sher; Ian R Gizer
Journal:  Alcohol Clin Exp Res       Date:  2020-02-18       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.